How to Help Your Patients Find Chorionic Gonadotropin in Stock: A Provider's Guide

Your Patients Need Chorionic Gonadotropin — Here's How to Help Them Find It

The Chorionic Gonadotropin shortage is one of those problems that creates extra work for everyone: patients spend hours calling pharmacies, your staff fields questions about backorders, and treatment timelines are disrupted. As a provider, you're in a unique position to streamline this process and help your patients get the medication they need with less frustration.

This guide provides practical, actionable steps your practice can implement to improve Chorionic Gonadotropin access for your patients in 2026. For the full shortage timeline and clinical background, see our provider shortage briefing.

Current Availability: What You Need to Know

As of early 2026, Chorionic Gonadotropin (HCG) remains in intermittent shortage. Here's the availability snapshot:

• Pregnyl (Organon, 10,000 units IM): Available intermittently; specialty pharmacies tend to have more consistent access
• Novarel (Ferring, 10,000 units IM): Similar intermittent pattern to Pregnyl
• Generic HCG for injection: Variable; some generics have maintained more consistent output
• Ovidrel (EMD Serono, 250 mcg SubQ, recombinant): Generally better availability than urinary-derived products

Key takeaway: availability varies significantly by pharmacy type, region, and distributor. Specialty pharmacies that serve fertility clinics typically have the most reliable supply.

Why Your Patients Can't Find It

Several factors contribute to patient difficulty beyond the shortage itself:

• Patients default to chain pharmacies. Large chains serve high volumes and deplete stock quickly. Patients may not know that specialty or independent pharmacies often have better access.
• No visibility into pharmacy inventory. Most patients' only option is to call pharmacies one by one — an inefficient, frustrating process that often ends with multiple dead ends.
• Prescription routing issues. E-prescribing to a pharmacy that's out of stock creates delays while the prescription is transferred and the patient starts the search over.
• Cost barriers. Even when available, prices of $100–$500+ per vial without insurance can lead patients to delay or abandon fill attempts.

What Providers Can Do: 5 Actionable Steps

Step 1: Check Stock Before Prescribing

The single most impactful change your practice can make is verifying pharmacy availability before sending the prescription. This prevents the common scenario where a patient receives a prescription, takes it to their pharmacy, learns it's out of stock, and then calls your office to start over.

Medfinder for Providers enables your staff to check real-time pharmacy inventory by entering the medication name and the patient's ZIP code. This takes less than a minute and can save hours of callbacks.

Step 2: Build Relationships with Specialty Pharmacies

Identify 2–3 specialty pharmacies in your area (or nationally, for mail-order) that consistently stock Chorionic Gonadotropin. Fertility-focused specialty pharmacies are the best starting point because they prioritize maintaining HCG inventory for their clinic partners.

Benefits of having go-to pharmacy partners:

• You can call ahead to reserve supply for upcoming treatment cycles
• They can alert you to impending shortages or new stock arrivals
• Patients get a warm referral instead of a cold search
• Some will hold inventory for scheduled protocols

Step 3: Prescribe Alternatives When Appropriate

Having a clear alternative protocol ready means you can pivot quickly when HCG is unavailable, rather than delaying treatment:

• For ovulation triggering: Ovidrel (Choriogonadotropin Alfa) 250 mcg SubQ — the most direct substitute. Or Leuprolide (Lupron) 1–2 mg SubQ as a trigger in GnRH antagonist protocols.
• For TRT adjunct: Clomiphene Citrate 25–50 mg oral daily or every other day to maintain endogenous gonadotropin stimulation. Widely available and affordable ($10–$30 per month).
• For cryptorchidism: If HCG is unavailable and hormonal treatment is not working or cannot be obtained, discuss surgical orchiopexy with the family as the definitive option.

For a comprehensive review of alternatives, see our alternatives guide.

Step 4: Educate Your Patients Proactively

Patients who understand the shortage cope better with it. Consider providing a brief handout or directing patients to reliable resources at the time of prescribing. Key points to communicate:

• The shortage is real and ongoing — it's not their pharmacy's fault
• Specialty pharmacies often have better supply than chains
• Real-time search tools like Medfinder can save time
• Discount programs can significantly reduce costs
• They should contact your office immediately if they can't fill the prescription, rather than waiting

Useful patient resources:

• How to find Chorionic Gonadotropin in stock
• Saving money on Chorionic Gonadotropin
• Shortage update for patients

Step 5: Plan Ahead for Time-Sensitive Protocols

For IVF cycles and other time-sensitive treatments, coordinate with your pharmacy partners at least 1–2 weeks before the anticipated trigger date. This gives them time to source the medication from distributors and ensures your patient won't face a last-minute scramble.

For TRT patients on ongoing HCG therapy, consider:

• Writing 90-day prescriptions to reduce refill frequency and improve pharmacy ordering
• Coordinating with the pharmacy to set up automatic refills when stock is available
• Having a documented backup plan (Clomiphene protocol) that can be activated immediately if HCG becomes unavailable

Alternatives at a Glance

A quick-reference table for your clinical team:

• Ovidrel (Choriogonadotropin Alfa): Recombinant HCG, 250 mcg SubQ prefilled syringe. Direct substitute for ovulation triggering. Cost: $200–$400+.
• Lupron Trigger (Leuprolide): GnRH agonist, 1–2 mg SubQ. For antagonist IVF protocols only. Reduced OHSS risk. Cost: $50–$150.
• Clomiphene Citrate (Clomid): SERM, 25–50 mg oral. Off-label for male hypogonadism/fertility preservation. Cost: $10–$30/month.
• Enclomiphene: Isomer of Clomiphene, similar mechanism. Emerging off-label option for men. Limited availability.
• Orchiopexy: Surgical option for cryptorchidism when pharmacological treatment is unavailable.

For detailed clinical guidance on each alternative, see our provider shortage briefing.

Workflow Tips for Your Practice

Integrate shortage management into your standard workflow to reduce disruption:

1. Designate a shortage coordinator. A staff member who monitors drug shortage databases (ASHP, FDA) and maintains relationships with specialty pharmacies can handle HCG sourcing for your entire practice.
2. Create a "shortage playbook." Document your preferred alternatives, pharmacy contacts, and patient communication templates so any provider or staff member can execute the plan.
3. Add a stock check to your prescribing workflow. Before e-prescribing HCG, have staff spend 60 seconds on Medfinder to confirm the receiving pharmacy has stock.
4. Track which pharmacies have the best availability. Keep a running list of pharmacies that consistently fill HCG prescriptions, and share it with your team.
5. Collect patient feedback. When patients report difficulty finding HCG, document which pharmacies were out of stock. This data helps you update your recommendations.

Final Thoughts

The Chorionic Gonadotropin shortage adds complexity to care delivery, but proactive pharmacy coordination, familiarity with alternatives, and patient education can minimize its impact on your patients' outcomes.

The most effective practices are the ones that check stock before prescribing, maintain specialty pharmacy relationships, and have documented backup protocols ready to activate at a moment's notice. Your patients are counting on you to navigate this — and with the right systems in place, you can.

For the patient perspective on costs and savings, see our guide on helping patients save money on Chorionic Gonadotropin.